Needham Reiterates Buy Rating on Veracyte, Inc (VCYT)

April 1, 2026 5:38 AM

Needham analyst Mike Matson reiterated a Buy rating and $48.00 price target on Veracyte, Inc (NASDAQ: VCYT).The analyst commented: "VCYT ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found